The biguanide drugs market is anticipated to grow at a considerable CAGR of more than 7.0% during the forecast period 2020-2026. Metformin IR (immediate release) and Metformin ER (Extended-release) are the most common biguanide in the global market. The growth in the patient pool of type 2 diabetes, increasing diagnosis rate in the emerging economies, […]
